ProQR Therapeutics (PRQR) Capital Leases (2013 - 2015)

ProQR Therapeutics' Capital Leases history runs 3 years deep, the most recent figure standing at $16.44 for Q4 2015.

• In Q4 2015, Capital Leases fell 99.96% year-over-year to $16.44; the TTM figure through Dec 2015 stood at $16.44 (down 99.96% YoY), while the FY2015 annual figure was $16.44, down 99.96% from the prior year.
• Capital Leases came in at $16.44 for Q4 2015 at ProQR Therapeutics, down from $33895.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $65332.3 in Q4 2013 to a low of $16.44 in Q4 2015.
• A 3-year average of $39231.4 and a median of $42494.3 in 2014 frame the typical range for Capital Leases.
• Across the five-year window, Capital Leases plunged 34.96% in 2014 and slumped 99.96% in 2015, its largest moves.
• ProQR Therapeutics' Capital Leases stood at $65332.3 in 2013, then plunged by 34.96% to $42494.3 in 2014, then plunged by 99.96% to $16.44 in 2015.
• According to Business Quant data, Capital Leases over the past three periods registered $16.44, $33895.0, and $42494.3 for Q4 2015, Q1 2015, and Q4 2014 respectively.

Peer Comparison